Free Trial

Beta Bionics (BBNX) Competitors

Beta Bionics logo
$22.90 +0.44 (+1.96%)
As of 04:00 PM Eastern

BBNX vs. TMDX, NVST, SLNO, LIVN, WRBY, LQDA, INSP, LMAT, PRCT, and AORT

Should you be buying Beta Bionics stock or one of its competitors? The main competitors of Beta Bionics include TransMedics Group (TMDX), Envista (NVST), Soleno Therapeutics (SLNO), LivaNova (LIVN), Warby Parker (WRBY), Liquidia Technologies (LQDA), Inspire Medical Systems (INSP), LeMaitre Vascular (LMAT), PROCEPT BioRobotics (PRCT), and Artivion (AORT). These companies are all part of the "medical equipment" industry.

Beta Bionics vs. Its Competitors

TransMedics Group (NASDAQ:TMDX) and Beta Bionics (NASDAQ:BBNX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, dividends, analyst recommendations, media sentiment, profitability, risk, institutional ownership and valuation.

In the previous week, TransMedics Group had 8 more articles in the media than Beta Bionics. MarketBeat recorded 12 mentions for TransMedics Group and 4 mentions for Beta Bionics. TransMedics Group's average media sentiment score of 0.59 beat Beta Bionics' score of 0.24 indicating that TransMedics Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
3 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Beta Bionics
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

99.7% of TransMedics Group shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

TransMedics Group has a net margin of 13.49% compared to Beta Bionics' net margin of 0.00%. TransMedics Group's return on equity of 28.02% beat Beta Bionics' return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group13.49% 28.02% 8.64%
Beta Bionics N/A N/A N/A

TransMedics Group has higher revenue and earnings than Beta Bionics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$441.54M9.66$35.46M$1.9364.84
Beta Bionics$65.12M15.29-$54.76MN/AN/A

TransMedics Group presently has a consensus price target of $125.40, suggesting a potential upside of 0.20%. Beta Bionics has a consensus price target of $23.33, suggesting a potential upside of 1.89%. Given Beta Bionics' stronger consensus rating and higher probable upside, analysts plainly believe Beta Bionics is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
Beta Bionics
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.75

Summary

TransMedics Group beats Beta Bionics on 9 of the 13 factors compared between the two stocks.

Get Beta Bionics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBNX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BBNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBNX vs. The Competition

MetricBeta BionicsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$976.34M$6.76B$5.80B$10.46B
Dividend YieldN/A1.21%5.61%4.57%
P/E RatioN/A26.38348.5626.86
Price / Sales15.29197.16549.90125.65
Price / CashN/A22.1426.0131.15
Price / Book-4.005.0615.536.50
Net Income-$54.76M$178.07M$3.29B$271.25M
7 Day Performance-9.52%1.53%200.87%3.69%
1 Month Performance34.31%6.98%184.38%8.07%
1 Year PerformanceN/A19.02%325.51%29.65%

Beta Bionics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBNX
Beta Bionics
0.922 of 5 stars
$22.90
+2.0%
$23.33
+1.9%
N/A$976.34M$65.12M0.00294Analyst Forecast
TMDX
TransMedics Group
2.2221 of 5 stars
$116.99
+8.5%
$122.11
+4.4%
-25.9%$3.67B$441.54M60.62210
NVST
Envista
3.7578 of 5 stars
$21.61
+4.0%
$20.92
-3.2%
+10.1%$3.45B$2.51B67.5312,300Positive News
SLNO
Soleno Therapeutics
4.4274 of 5 stars
$56.72
-5.5%
$115.09
+102.9%
+6.1%$3.19BN/A-13.7030
LIVN
LivaNova
2.7297 of 5 stars
$57.34
+1.5%
$59.71
+4.1%
+8.4%$3.09B$1.25B-14.742,900Positive News
WRBY
Warby Parker
1.4371 of 5 stars
$27.56
+2.0%
$24.06
-12.7%
+99.4%$2.84B$771.32M-393.663,780Positive News
Insider Trade
LQDA
Liquidia Technologies
3.9385 of 5 stars
$27.00
-1.1%
$32.11
+18.9%
+139.0%$2.35B$14M-15.8850
INSP
Inspire Medical Systems
4.8456 of 5 stars
$82.62
+4.9%
$164.50
+99.1%
-62.5%$2.33B$802.80M47.761,246Analyst Forecast
Gap Down
LMAT
LeMaitre Vascular
3.0654 of 5 stars
$94.23
+1.7%
$97.60
+3.6%
+2.5%$2.10B$234.64M45.74490Positive News
PRCT
PROCEPT BioRobotics
2.7572 of 5 stars
$38.64
+3.0%
$73.22
+89.5%
-56.0%$2.09B$224.50M-24.93430Positive News
AORT
Artivion
2.5653 of 5 stars
$42.26
+3.0%
$40.63
-3.8%
+61.0%$1.94B$388.54M-100.621,600Positive News

Related Companies and Tools


This page (NASDAQ:BBNX) was last updated on 9/22/2025 by MarketBeat.com Staff
From Our Partners